Centralization and Equitable Care in Rare Urogenital Malignancies: The Case for Penile Cancer

Jakob K. Jakobsen*, Curtis A. Pettaway, Benjamin Ayres

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

Abstract

Centralization of specialized care for rare cancers can improve patient outcomes. Inguinal lymph node evaluation is the most important clinical aspect of penile cancer care and is often neglected in a decentralized setting. Centralization of care may reduce system delays, improve guideline adherence, provide access to a wider team of specialists, and improve prognosis, albeit with some inconveniences for patients. Patient summary: We reviewed evidence for the centralization of care for penile cancer. Patients may have to travel greater distances to receive specialized care in expert centers. However, centralization means that rare cancers can be treated by more experienced surgeons, which can yield better outcomes in terms of survival and penis-preserving or reconstruction surgery.

Original languageEnglish
JournalEuropean Urology Focus
Volume7
Issue5
Pages (from-to)924-928
Number of pages5
DOIs
Publication statusPublished - Sept 2021

Keywords

  • Health service centralization
  • Lymph node evaluation
  • Penile cancer
  • Prognosis

Fingerprint

Dive into the research topics of 'Centralization and Equitable Care in Rare Urogenital Malignancies: The Case for Penile Cancer'. Together they form a unique fingerprint.

Cite this